Agios Pharmaceuticals Inc. (AGIO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Agios Pharmaceuticals Inc...

    NASDAQ: AGIO · Real-Time Price · USD
    38.93
    2.32 (6.34%)
    At close: Sep 26, 2025, 3:59 PM
    38.93
    0.00%
    After-hours: Sep 26, 2025, 07:39 PM EDT

    Agios Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 76.25M 88.2M 139.26M 203.13M
    Short-Term Investments
    		 817.46M 688.72M 643.86M 816.89M
    Long-Term Investments
    		 638.32M 29.43M 313.87M 266.38M
    Other Long-Term Assets
    		 4.72M 4.06M 3.96M 2.9M
    Receivables
    		 4.11M 2.81M 2.21M 4.38M
    Inventory
    		 27.62M 19.08M 8.49M 16.19M
    Other Current Assets
    		 40.16M 35.02M 38.95M n/a
    Total Current Assets
    		 965.6M 833.84M 832.77M 1.06B
    Property-Plant & Equipment
    		 54.55M 69.79M 88.12M 104.23M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 697.6M 103.28M 405.95M 373.5M
    Total Assets
    		 1.66B 937.12M 1.24B 1.44B
    Account Payables
    		 16.64M 9.78M 18.62M 16.7M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 46.86M 23.23M 12.24M 12.15M
    Total Current Liabilities
    		 81.16M 67.95M 62.63M 59.83M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 41.09M 1.16M 3.28M n/a
    Total Long-Term Liabilities
    		 41.09M 58.14M 75.28M 85.94M
    Total Liabilities
    		 122.24M 126.1M 137.9M 145.76M
    Total Debt
    		 56.99M 72M 85.66M 97.09M
    Book Value
    		 1.54B 811.02M 1.1B 1.29B
    Book Value Per Share
    		 27.13 14.57 20.09 21.37
    Common Stock
    		 73K 72K 71K 71K
    Retained Earnings
    		 -148.92M -822.65M -470.56M -238.76M
    Comprehensive Income
    		 -1.52M -441K -12.54M -1.2M
    Shareholders Equity
    		 1.54B 811.02M 1.1B 1.29B
    Total Investments
    		 1.46B 718.16M 957.73M 1.08B

    Add to Watchlist